For B16F10-bearing mice, tumour cells were harvested for flow cytometry analysis of PD-L1, demonstrating that treatment with aT-sEVs significantly reduced the expression of cell membrane PD-L1 (Supplementary Fig. 4e). This evidence concerns the gene CD274 and neoplasm.